BIOMAT Database Logo BIOMAT Database Logo

[Sipple syndrome]. 1996

P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
Department of Surgical Diseases No1, Moscow Medical Academy of IM Sechenov.

UI MeSH Term Description Entries
D009679 Nuclear Family A family composed of spouses and their children. Daughters,Sons,Daughter,Families, Nuclear,Family, Nuclear,Nuclear Families,Son
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000310 Adrenal Gland Neoplasms Tumors or cancer of the ADRENAL GLANDS. Adrenal Cancer,Adrenal Gland Cancer,Adrenal Neoplasm,Cancer of the Adrenal Gland,Neoplasms, Adrenal Gland,Adrenal Cancers,Adrenal Gland Cancers,Adrenal Gland Neoplasm,Adrenal Neoplasms,Cancer, Adrenal,Cancer, Adrenal Gland,Cancers, Adrenal,Cancers, Adrenal Gland,Neoplasm, Adrenal,Neoplasm, Adrenal Gland,Neoplasms, Adrenal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018813 Multiple Endocrine Neoplasia Type 2a A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease. MEN 2,MEN 2a,Neoplasia, Multiple Endocrine Type 2a,Neoplasms, Multiple Endocrine Type 2a,Sipple Syndrome,MEA 2a,MEA II,MEA IIa,MEN II,MEN IIa,MEN-2A Syndrome,MEN2a,Multiple Endocrine Neoplasia Type 2,Multiple Endocrine Neoplasia, Type IIa,Multiple Endocrine Neoplasms Type 2a,Pheochromocytoma And Amyloid-Producing Medullary Thyroid Carcinoma,MEN 2A Syndrome,MEN-2A Syndromes,Pheochromocytoma And Amyloid Producing Medullary Thyroid Carcinoma

Related Publications

P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
Sipple syndrome.
February 1989, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
[Sipple syndrome and pregnancy].
January 1991, Annales de medecine interne,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
[Sipple syndrome (author's transl)].
September 1974, Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
Sipple syndrome and pregnancy.
March 1976, JAMA,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
Computed tomography of Sipple syndrome.
February 1984, Journal of computer assisted tomography,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
[Hereditary Sipple syndrome (author's transl)].
February 1977, Annales de dermatologie et de venereologie,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
[Preoperative cytological diagnosis of Sipple syndrome].
January 1995, Klinicheskaia meditsina,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
Medullary thyroid carcinoma in Sipple syndrome.
November 1979, The Johns Hopkins medical journal,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
Sipple syndrome and acute lymphoblastic leukemia.
January 1975, JAMA,
P S Vetshev, and G A Mel'nichenko, and N S Kuzhetsov, and L I Ippolitov, and N A Solov'eva
[A new case of the Sipple syndrome].
January 1987, Problemy endokrinologii,
Copied contents to your clipboard!